BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38736351)

  • 1. Intranasal Corticosteroids: A Personalized Medicine Approach.
    Boldes T; Nageris B; Kassem F; Biadsee A
    Isr Med Assoc J; 2024 May; 26(5):324-332. PubMed ID: 38736351
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision Medicine Urgency: The Case of Inhaled Corticosteroids in COPD.
    Suissa S; Ernst P
    Chest; 2017 Aug; 152(2):227-231. PubMed ID: 28797382
    [No Abstract]   [Full Text] [Related]  

  • 3. Using intranasal corticosteroids.
    Fowler J; Sowerby LJ
    CMAJ; 2021 Jan; 193(2):E47. PubMed ID: 33431545
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical intranasal corticosteroids for otitis media with effusion in primary care.
    Damoiseaux RA; Rovers MM
    BMJ; 2010 Jan; 340():b5380. PubMed ID: 20056694
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular symptom efficacy and intranasal corticosteroids.
    Keith PK; Toler WT; Lee LA
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):539; author reply 539-40. PubMed ID: 20084852
    [No Abstract]   [Full Text] [Related]  

  • 6. Intranasal corticosteroids and cromolyn.
    Mabry RL
    Am J Otolaryngol; 1993; 14(5):295-300. PubMed ID: 8238756
    [No Abstract]   [Full Text] [Related]  

  • 7. Intranasal corticosteroids reduce ocular symptoms of allergic rhinitis as a class effect.
    Bielory L
    J Allergy Clin Immunol; 2008 Feb; 121(2):538-9. PubMed ID: 18158174
    [No Abstract]   [Full Text] [Related]  

  • 8. Intranasal corticosteroids for the treatment of perennial allergic rhinitis.
    Stokes J
    South Med J; 2007 Jul; 100(7):667-8. PubMed ID: 17639744
    [No Abstract]   [Full Text] [Related]  

  • 9. Current categorisation of allergic rhinitis and sensory perceptions to intranasal corticosteroids: clinical implications.
    Shah A
    Indian J Chest Dis Allied Sci; 2005; 47(3):157-9. PubMed ID: 16022141
    [No Abstract]   [Full Text] [Related]  

  • 10. The subtle nuances of intranasal corticosteroids.
    Fowler J; Rotenberg BW; Sowerby LJ
    J Otolaryngol Head Neck Surg; 2021 Mar; 50(1):18. PubMed ID: 33731223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for awareness about interaction between nonprescription intranasal corticosteroids and pharmacokinetic enhancers.
    Nelson B; Cluck D; Alexander K; Underwood RF; Cross LB
    Am J Health Syst Pharm; 2015 Jul; 72(13):1086-8. PubMed ID: 26092956
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal and inhaled corticosteroids in allergic rhinitis and asthma.
    Lee DK; Lipworth BJ
    Br J Clin Pharmacol; 2004 Oct; 58(4):447-8. PubMed ID: 15373942
    [No Abstract]   [Full Text] [Related]  

  • 13. Over-the-counter intranasal corticosteroids: empowering the patient or putting them in harm's way?
    Khan DA
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):506-8. PubMed ID: 16680918
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Intranasal Corticosteroids on Secondary Sinonasal Symptoms: A Systematic Review of Randomized Trials.
    Deot N; Barr J; Mankowski N; Brunner J; McCoul ED
    Am J Rhinol Allergy; 2019 Sep; 33(5):601-607. PubMed ID: 31035786
    [No Abstract]   [Full Text] [Related]  

  • 15. Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology.
    Bielory L; Blaiss M; Fineman SM; Ledford DK; Lieberman P; Simons FE; Skoner DP; Storms WW; ;
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):514-25. PubMed ID: 16680921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive intracranial aspergillosis secondary to intranasal corticosteroids.
    Lewis MB; Henderson B
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):416-7. PubMed ID: 10577034
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticosteroids in rhinology.
    Mabry RL
    Otolaryngol Head Neck Surg; 1993 Jun; 108(6):768-70. PubMed ID: 8516019
    [No Abstract]   [Full Text] [Related]  

  • 18. Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids.
    Lipworth BJ; Seckl JR
    Thorax; 1997 May; 52(5):476-82. PubMed ID: 9176542
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of inhaled and intranasal corticosteroids.
    Ahmadiafshar A; Ahmadiafshar S
    Antiinflamm Antiallergy Agents Med Chem; 2014; 13(2):83-7. PubMed ID: 25175908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function.
    Fan Y; Ma L; Pippins J; Limb S; Xu Y; Sahajwalla CG
    J Pharm Sci; 2014 Oct; 103(10):2963-79. PubMed ID: 25103275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.